Cargando…

Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series

Idiopathic multicentric Castleman disease (iMCD) is a systemic and polyclonal lymphoproliferative disease involving multiple organs, including the kidneys, due to the overproduction of interleukin-6 (IL-6). Recently, several reports have suggested that excessive IL-6 actions in iMCD could have a cau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kojima, Daiki, Yamaguchi, Shintaro, Hashiguchi, Akinori, Hayashi, Kaori, Uchiyama, Kiyotaka, Yoshimoto, Norifumi, Adachi, Keika, Nakayama, Takashin, Nishioka, Ken, Tajima, Takaya, Morimoto, Kohkichi, Yoshino, Jun, Yoshida, Tadashi, Monkawa, Toshiaki, Kanda, Takeshi, Itoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868391/ https://www.ncbi.nlm.nih.gov/pubmed/36698794 http://dx.doi.org/10.3389/fmed.2022.1037032

Ejemplares similares

Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
por: Nakayama, Takashin, et al.
Publicado: (2023)

Antineutrophil cytoplasmic antibody-associated vasculitis predominantly manifesting tubulointerstitial nephritis: A case report
por: Nishioka, Ken, et al.
Publicado: (2023)

Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study
por: Uchiyama, Kiyotaka, et al.
Publicado: (2022)

Late Dialysis Modality Education Could Negatively Predict Peritoneal Dialysis Selection
por: Nakayama, Takashin, et al.
Publicado: (2022)

Development of Alveolar Hemorrhage After Pfizer-BioNTech COVID-19 mRNA Vaccination in a Patient With Renal-Limited Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report
por: Nishioka, Ken, et al.
Publicado: (2022)

Bullous pemphigoid in patients receiving peritoneal dialysis: a case series and a literature survey
por: Morimoto, Kohkichi, et al.
Publicado: (2021)

The body mass index change is associated with death or hemodialysis transfer in Japanese patients initiating peritoneal dialysis
por: Kojima, Daiki, et al.
Publicado: (2023)

Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
por: Uchiyama, Kiyotaka, et al.
Publicado: (2022)

Health-Related Quality of Life Sleep Score Predicts Transfer to Hemodialysis among Patients on Peritoneal Dialysis
por: Nagasaka, Tomoki, et al.
Publicado: (2022)

Fibronectin Glomerulopathy Confused with Glomerular Endothelial Injury in a Patient with Takotsubo Cardiomyopathy
por: Azegami, Tatsuhiko, et al.
Publicado: (2021)

Home-Based Exercise Program Ameliorates Renal Function Decline in Patients With CKD Stage 4
por: Adachi, Keika, et al.
Publicado: (2022)

Sodium benzoate attenuates 2,8-dihydroxyadenine nephropathy by inhibiting monocyte/macrophage TNF-α expression
por: Oshima, Yoichi, et al.
Publicado: (2023)

DNA repair factor KAT5 prevents ischemic acute kidney injury through glomerular filtration regulation
por: Hishikawa, Akihito, et al.
Publicado: (2021)

Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial
por: Uchiyama, Kiyotaka, et al.
Publicado: (2021)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Home-based Aerobic Exercise and Resistance Training in Peritoneal Dialysis Patients: A Randomized Controlled Trial
por: Uchiyama, Kiyotaka, et al.
Publicado: (2019)

Cerebral angiitis associated with subarachnoid hemorrhage in Castleman’s disease: report of two cases
por: Tanaka, Jun, et al.
Publicado: (2016)

PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease
por: Kozlova, A, et al.
Publicado: (2013)

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
por: Aita, Tetsuro, et al.
Publicado: (2020)

Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
por: Togitani, Kazuto, et al.
Publicado: (2022)

Association of glomerular DNA damage and DNA methylation with one-year eGFR decline in IgA nephropathy
por: Hayashi, Kaori, et al.
Publicado: (2020)

Vaccination against connective tissue growth factor attenuates the development of renal fibrosis
por: Nakayama, Takashin, et al.
Publicado: (2022)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
por: Han, Ping-Yang, et al.
Publicado: (2020)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Correlation between acylcarnitine/free carnitine ratio and cardiopulmonary exercise test parameters in patients with incident dialysis
por: Ito, Wataru, et al.
Publicado: (2023)

Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
por: Tabata, Sakiko, et al.
Publicado: (2019)

Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial
por: Koga, Tomohiro, et al.
Publicado: (2020)

Historical and pathological overview of Castleman disease
por: Nishimura, Midori Filiz, et al.
Publicado: (2022)

Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports
por: Ryuzaki, Masaki, et al.
Publicado: (2019)

A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment
por: Filippini, M., et al.
Publicado: (2018)

Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature
por: Saiki, Ryosuke, et al.
Publicado: (2021)

Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome – effective treatment with tocilizumab
por: Kwiatkowska, Małgorzata, et al.
Publicado: (2015)

An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant)
por: Koga, Tomohiro, et al.
Publicado: (2020)

A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis
por: Yamaguchi, Shintaro, et al.
Publicado: (2015)

Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report
por: Sugawara, Eri, et al.
Publicado: (2022)

The impact of a remote monitoring system of healthcare resource consumption in patients on automated peritoneal dialysis (APD): A simulation study
por: Uchiyama, Kiyotaka, et al.
Publicado: (2018)

Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG(4)-positive plasma cells: A case report
por: Katsumata, Yusuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d10uk0348vaj82nv2tukafe8l8